DNTH
NASDAQ · Biotechnology
Dianthus Therapeutics Inc
$109.92
-2.58 (-2.29%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+108.54%
1Y
+485.93%
YTD
+177.02%
Open$111.93
Previous Close$112.50
Day High$114.14
Day Low$106.86
52W High$114.55
52W Low$18.08
Volume—
Avg Volume840.5K
Market Cap6.05B
P/E Ratio—
EPS$-4.15
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$45.37
Above
SMA 200
$31.95
Above
RSI (14)
42.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
22 analysts
Price Target
-64.7% upside
Current
$109.92
$109.92
Target
$38.82
$38.82
$27.89
$38.82 avg
$53.79
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.90M | 305.72M | 270.76M |
| Net Income | -231,505,545 | -32,339,215 | -26,813,974 |
| Profit Margin | -7,973.3% | -10.6% | -9.9% |
| EBITDA | -253,589,358 | -32,605,970 | -27,281,394 |
| Free Cash Flow | — | -20,890,110 | -21,520,158 |
| Rev Growth | — | +9.7% | -3.3% |
| Debt/Equity | — | 0.57 | 0.83 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |